Peter Leary, MD
Enriched profileProfessor, Division of Pulmonary, Critical Care and Sleep Medicine; Director, Pulmonary Vascular Disease Program · University of Washington Medical Center
Peter Leary is Professor, Division of Pulmonary, Critical Care and Sleep Medicine; Director, Pulmonary Vascular Disease Program at University of Washington Medical Center. OpenAlex indexes 142 publications with 2,403 citations (h-index 25); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Peter Leary, MD MS, is Professor, Division of Pulmonary, Critical Care and Sleep Medicine at University of Washington Medical Center, Seattle, WA. The public record shows 142 publications with 2,403 citations (h-index 25), centered on Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 7 companies, 6 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · Catheterization and cardiovascular interventions
- Top research focus: Pulmonary Hypertension Research and Treatments
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 44.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Repurposing Valsartan May Protect Against Pulmonary Hypertension
Sponsor: University of Washington
- Pulmonary Hypertension Association Registry
Sponsor: Pulmonary Hypertension Association, Inc.
- Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
Sponsor: University of Washington
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20254 payments
- Actelion Pharmaceuticals US, Inc.Program year20251 payment
- ABIOMEDProgram year20252 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
56.2%Endothelin Receptor Antagonist42.9%Ambrisentan55%Opsumit45%Part D≥36 patientsSoluble Guanylate Cyclase Stimulator5.3%Adempas100%Part D<11 patientsGenitourinary & hormones
22%Phosphodiesterase 5 Inhibitor22%Sildenafil Citrate65%Tadalafil30%Revatio5%Part D<11 patientsBlood & clotting
19.1%Prostacyclin Receptor Agonist15.1%Uptravi100%Part D≥26 patientsFactor Xa inhibitor2.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
6 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- TEMPO-PH (Temporal Evolution and Multi-omic Profiles in Pulmonary Hypertension)
University of Washington
FY2026$773,815R01HL188754 - REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
University of Washington
FY2025$750,608R33HL167848 - REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
University of Washington
FY2024$753,917R33HL167848
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Successful Revascularization of Chronic Total Occlusions in Patients With Chronic Thromboembolic Pulmonary Disease.
Catheterization and cardiovascular interventions
Article2026 - A Metabolomics Roadmap to Right Ventricular Function in Pulmonary Hypertension.
Circulation research
Editorial2026 - Integrative Multiomics for Prognostic Assessment in Pulmonary Arterial Hypertension.
Circulation. Heart failure
Letter2025 - Effects of Implementing a Standardized Risk Stratification and Triage Workflow for an Established Pulmonary Embolism Response Team.
Annals of the American Thoracic Society
Article2025
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/peter-leary-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Peter-Leary-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pulmccsm.uw.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor
Department of Epidemiology, University of Washington School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pulmccsm.uw.edu ↗
Media & interviews
press, podcasts and appearances- phaware podcast: "I'm Aware That I'm Rare"
multi-part interview series (PE and CTEPH episodes) discussing pulmonary hypertension clinical research and methamphetamine-associated PH stigma
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →phaware.medium.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ganesh Raghu, MD
University of Washington Medical Center
Ali Samii
University of Washington Medical Center
Mark Wener
University of Washington Medical Center
Creighton Don, MD, PhD
University of Washington Medical Center